Loiseau P M, German M
Chimiothérapie antiparasitaire, UMR 8076 CNRS BioCIS, faculté de Pharmacie de l'Université Paris-Saclay, 5, rue Jean-Baptiste Clément, 92290 Chatenay-Malabry, France.
Sciences biologiques appliquées à la santé humaine, académie nationale de Pharmacie, France.
Ann Pharm Fr. 2022 Nov;80(6):778-781. doi: 10.1016/j.pharma.2022.04.003. Epub 2022 Apr 26.
Leptospirosis is a cosmopolitan infectious disease caused by the bacteria Leptospirainterrogans, which is worldwide increasing as the result of climate changes favoring the reproduction of asymptomatic reservoir rodents and also flooding that brings mammals and humans into contact with contaminated water. This disease affects many mammals among wild, domestic or farmed animals. In humans, it is manifested through frustrated to severe forms that can lead to liver and kidney failure and death in about one in ten severe cases. Diagnostic methods and treatments are satisfactory. Prophylaxis is based on individual protective measures including vaccination. The single human vaccine that is available is expensive and it protects 97% against about a third of human pathogenic serovars. Moreover, this vaccine is not covered by health insurance. Better epidemiological knowledge, particularly at European level, could stimulate research in this area in order to obtain a vaccine that would protect more comprehensively against serovars pathogenic to humans.
钩端螺旋体病是一种由问号钩端螺旋体细菌引起的全球性传染病。由于气候变化有利于无症状宿主啮齿动物的繁殖,以及洪水使哺乳动物和人类接触到受污染的水,该病在全球范围内呈上升趋势。这种疾病影响许多野生、家养或养殖动物中的哺乳动物。在人类中,它表现为从轻症到重症的多种形式,在约十分之一的重症病例中可导致肝肾功能衰竭和死亡。诊断方法和治疗方法令人满意。预防措施基于包括疫苗接种在内的个人防护措施。现有的单一人类疫苗价格昂贵,可针对约三分之一的人类致病血清型提供97%的保护。此外,这种疫苗不在医疗保险范围内。更好的流行病学知识,特别是在欧洲层面,可能会刺激该领域的研究,以获得一种能更全面地预防对人类致病血清型的疫苗。